US Stock MarketDetailed Quotes

OTLKW Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A

Watchlist
  • 0.000
  • 0.0000.00%
Close Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)

About Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A Company

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Company Profile

SymbolOTLKW
Company NameOutlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A
CEOMr. C. Russell Trenary, III
MarketNASDAQ
Employees9
Websitehttps://www.outlooktherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • C. Russell Trenary, III
  • Director, President and Chief Executive Officer
  • --
  • Lawrence A. Kenyon
  • Director, Executive Vice President, Treasurer, Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
  • --
  • Terry Dagnon
  • Chief Operating Officer
  • --
  • Jeff Evanson
  • Chief Commercial Officer
  • --
  • Ralph H. Thurman
  • Executive Chairman of the Board
  • --
  • Yezan Munther Haddadin
  • Independent Director
  • --
  • Kurt J. Hilzinger
  • Independent Director
  • --
  • Julian S. Gangolli
  • Independent Director
  • --
  • Dr. Gerd U. Auffarth
  • Independent Director
  • --
  • Faisal G. Sukhtian
  • Independent Director
  • --
  • Andong Huang
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data